Stocks to watch for Wednesday:Synergy Pharma (SGYP) - the small biotech took a massive 8.5% hit on Tuesday. Synergy is now at the yearly lows. The stock is down some 35% following the highs after the approval of Trulance. As highlighted in several posts, stocks tend to dip from approval to official launch. Analyst Timothy Chang of BTIG reiterated the $11 price target which is good enough for an incredible 135% gain. Synergy Pharma appears a buy here as the market frets the launch of Trulance. Novavax (NVAX) - another biotech hit by 8% on Tuesday. This stock has been straight downhill after turning more positive on the name a week or so ago. Not sure I'd add after the trading action today, but the stock is increasingly appealing as the company gets further along with pivotal trials. Twilio (TWLO) - as stated many times here in the past, this stock was interesting if $30 holds. The trading action today and close below $30 would have me on the sidelines with Twilio. These high risk stock plays are suddenly out of favor with the market and this stock has no valuation support at these levels. Acacia Communications (ACIA) - of all the stocks to hold up today with only a 1% loss, Acacia has started to trade in a more bullish pattern. Not convinced the stock holds $50 yet. Snap (SNAP) - another buy rating with the stock above $20 is just ridiculous. Drexel Hamilton has the craziest target of $30. A market value of somewhere around $45 billion is absurd. Use any rally tomorrow to immediately dump shares. Click on the Sign in/Sign up button in the top right corner to join for free to comment on your stock moves for tomorrow.Click on the Follow button to get the daily blog posts from Out Fox The $treet.Disclosure: No position